04.01.2026, 595 Zeichen

Valneva: Valneva SE, a specialty vaccine company, and Serum Institute of India, a Cyrus Poonawalla Group company today announced that they have mutually agreed to discontinue their license agreement for Valneva's single-shot chikungunya vaccine. Valneva's strategic intent in regaining full rights is to assume direct control over its supply chain and commercialization for endemic high-risk countries, thereby accelerating access for regions most affected by the disease.
Valneva: weekly performance: 5.10%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (31/12/2025)

Christian Drastil: Wiener Börse Plausch

BörseGeschichte Podcast: Ernst Vejdovszky vor 10 Jahren zum ATX-25er

Bildnachweis

Aktien auf dem Radar:Polytec Group, Addiko Bank, UBM, RHI Magnesita, Zumtobel, Agrana, Rosgix, CA Immo, DO&CO, SBO, Gurktaler AG Stamm, Heid AG, OMV, Wolford, Palfinger, Rosenbauer, Oberbank AG Stamm, BTV AG, Flughafen Wien, BKS Bank Stamm, Josef Manner & Comp. AG, Mayr-Melnhof, Athos Immobilien, Marinomed Biotech, Amag, Österreichische Post, Verbund, Wienerberger, Merck KGaA, Continental, Fresenius Medical Care.

---